Drug Search Results
Using advanced filters...
Advanced Search [+]

Acemetacin

Alternative Names: acemetacin
Latest Update: 2025-02-11
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: COX Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | Bosnia | Brazil | Colombia | Croatia | Dominican Republic | Egypt | Germany | Greece | Hong Kong | Hungary | Ireland | Italy | Korea | Luxembourg | Malta | Mexico | Morocco | Pakistan | Peru | Poland | Portugal | Russia | Serbia | Switzerland | Taiwan | Thailand | Turkey | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: CannaXan
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events